venlafaxine hydrochloride has been researched along with Stroke in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bronfman, FC; Contreras, V; Lazo, OM; Owen, GI; Pissani, C; Stack, K; Vargas, M; Zepeda, R | 1 |
Caltagirone, C; Cravello, L; Spalletta, G | 1 |
Boerstoel-Streefland, M; Duh, MS; Guérin, A; Jiang, W; Lefebvre, P; Mease, PJ; Vekeman, F; Zimetbaum, PJ | 1 |
Rakun, R; Ružić, K; Sabljić, V | 1 |
Dai, MH; Han, Y; Li, DQ | 1 |
Douglas, JE; Jenkins, EA; Montealegre-Orjuela, M; Smith, AG | 1 |
Devarajan, S; Dursun, SM; Haddad, PM | 1 |
1 trial(s) available for venlafaxine hydrochloride and Stroke
Article | Year |
---|---|
The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression.
Topics: Aged; Cyclohexanols; Depressive Disorder; Emotions; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Self Concept; Stroke; Venlafaxine Hydrochloride | 2009 |
6 other study(ies) available for venlafaxine hydrochloride and Stroke
Article | Year |
---|---|
Venlafaxine treatment after endothelin-1-induced cortical stroke modulates growth factor expression and reduces tissue damage in rats.
Topics: Animals; Antidepressive Agents; Astrocytes; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelin-1; Fibroblast Growth Factor 2; Gliosis; Male; Neuroprotective Agents; Random Allocation; Rats, Sprague-Dawley; Recovery of Function; RNA, Messenger; Stroke; Transforming Growth Factor beta1; Venlafaxine Hydrochloride | 2016 |
Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data.
Topics: Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Antidepressive Agents; Cardiovascular Diseases; Cyclopropanes; Female; Heart Failure; Humans; Male; Middle Aged; Milnacipran; Myocardial Infarction; Retrospective Studies; Risk; Selective Serotonin Reuptake Inhibitors; Stroke; United States; Venlafaxine Hydrochloride | 2011 |
Venlafaxine withdrawal syndrome.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Ischemic Attack, Transient; Retreatment; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2011 |
[Effect of venlafaxine on cognitive function and hippocampal brain-derived neurotrophic factor expression in rats with post-stroke depression].
Topics: Animals; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Rats; Rats, Sprague-Dawley; Stroke; Venlafaxine Hydrochloride | 2011 |
Venlafaxine for pathological crying after stroke.
Topics: Affective Symptoms; Aged; Crying; Cyclohexanols; Humans; Male; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Diagnosis, Differential; Dysthymic Disorder; Female; Humans; Paroxetine; Stroke; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2001 |